CDEK
← All organizations

Prestwick Pharmaceuticals

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 14, 2005

First marketed drug

Aug 15, 2008

First NDA

Aug 15, 2008

Last known activity

Sep 14, 2005

Acquired by Biovail → Bausch Health Companies on Jan 1, 2008

Timeline

2000s

  1. Jan 1, 2002

    Prestwick Pharmaceuticals— Founded

  2. Jan 1, 2008

    Biovail— Acquired By

  3. Aug 15, 2008

    tetrabenazine— NDA Organization

2010s

  1. Jan 1, 2010

    Bausch Health Companies— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (1)

Details

Founded
Washington DC, US Jan 1, 2002
First NDA
Aug 15, 2008
Last known activity
Sep 14, 2005

Designations held

  • Orphan drug
  • Priority review

Notes

Acquired by Biovail